These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7422708)

  • 1. Disposition and metabolism of adriamycin in the rat.
    Tavoloni N; Guarino AM
    Pharmacology; 1980; 21(4):244-55. PubMed ID: 7422708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile secretory function: a determinant of adriamycin disposition.
    Tavoloni N; Guarino AM
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):180-97. PubMed ID: 7406604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary and urinary excretion of adriamycin in anesthetized rats.
    Tavoloni N; Guarino AM
    Pharmacology; 1980; 20(5):256-67. PubMed ID: 7393994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
    Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
    Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of route administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat.
    Parker RJ; Priester ER; Sieber SM
    Drug Metab Dispos; 1982; 10(5):499-504. PubMed ID: 6128200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative metabolism and elimination of adriamycin and 4'-epiadriamycin in the rat.
    Sweatman TW; Israel M
    Cancer Chemother Pharmacol; 1987; 19(3):201-6. PubMed ID: 3472675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.
    Israel M; Wilkinson PM; Pegg WJ; Frei E
    Cancer Res; 1978 Feb; 38(2):365-70. PubMed ID: 620407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat model.
    Behnia K; Boroujerdi M
    Cancer Chemother Pharmacol; 1998; 41(5):370-6. PubMed ID: 9523732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
    Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
    Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilary disposition of adriamycin.
    Riggs CE; Benjamin RS; Serpick AA; Bachur NR
    Clin Pharmacol Ther; 1977 Aug; 22(2):234-41. PubMed ID: 884924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine metabolism and disposition of iron:adriamycin complexes.
    Egorin MJ; Clawson RE; Ross LA; Friedman RD; Reich SD; Pollak A; Bachur NR
    Cancer Res; 1983 Jul; 43(7):3253-62. PubMed ID: 6189594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.
    Han G; Israel M; Seshadri R; Dalton JT; Sweatman TW
    Cancer Chemother Pharmacol; 1996; 37(5):472-8. PubMed ID: 8599871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study.
    Arcamone F; Lazzati M; Vicario GP; Zini G
    Cancer Chemother Pharmacol; 1984; 12(3):157-66. PubMed ID: 6584234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum.
    Cummings J; Milstead R; Cunningham D; Kaye S
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):991-1001. PubMed ID: 3770056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
    Cummings J; Merry S; Willmott N
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration].
    Tone H; Iguchi H; Fujigaki M; Nishio M; Esumi Y; Takaichi M; Tsutsumi S; Yokoshima T
    Jpn J Antibiot; 1986 Feb; 39(2):612-28. PubMed ID: 3712761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats.
    Broggini M; Colombo T; Martini A; Donelli MG
    Cancer Treat Rep; 1980; 64(8-9):897-904. PubMed ID: 6934850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.